Allergan Aesthetics & Girls Inc. Mark 6 Years, Urge Pledge for STEM Mentorship
Allergan Aesthetics, a part of AbbVie, has announced its sixth consecutive year of partnering with Girls Inc. to encourage high school and college girls’ interest in STEM (science, technology, engineering,…
Gilead Partners with Six Generics for Royalty-Free Licensing of Lenacapavir in High-Incidence HIV Regions
Gilead Sciences, Inc. (Nasdaq: GILD) has announced the signing of non-exclusive, royalty-free voluntary licensing agreements with six pharmaceutical manufacturers to produce and distribute generic lenacapavir in 120 high-incidence, resource-limited countries,…
FDA Approves Opdivo with Chemotherapy for Resectable NSCLC Treatment
Bristol Myers Squibb (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo® (nivolumab) for the treatment of adult patients with resectable non-small cell lung…
La La Anthony Teams Up with Amgen to Share How Plaque Psoriasis Impacts Her Life
Amgen (NASDAQ: AMGN) has teamed up with actress, producer, and entrepreneur La La Anthony to highlight her personal experience with plaque psoriasis and inspire others to have open conversations with…
Enhertu Receives Priority Review in the US for HER2-Low/Ultralow Metastatic Breast Cancer Post-Endocrine Therapy
AstraZeneca and Daiichi Sankyo have announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to their supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab…
Calquence Receives Priority Review in the U.S. for Newly Diagnosed Mantle Cell Lymphoma Patients
AstraZeneca’s supplemental New Drug Application (sNDA) for Calquence (acalabrutinib) has been accepted for Priority Review by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with…
Lilly Unveils $4.5B Medicine Foundry for Drug Innovation and Clinical Trials
Eli Lilly and Company (NYSE: LLY) announced a significant $4.5 billion investment to establish the Lilly Medicine Foundry, a state-of-the-art facility for advanced manufacturing and drug development. This innovative center…
AIVITA Biomedical Partners with LevEllis to License Innovative Skincare Formulations
AIVITA Biomedical, Inc., a biotech firm focused on pioneering stem cell applications, has announced a licensing agreement with LevEllis, a global skincare retailer. This partnership grants LevEllis the exclusive worldwide…
PharmaJet Announces Dr. Wouter Latour as the New Chief Executive Officer
PharmaJet®, a leader in enhancing the efficacy of injectable treatments through innovative technology, has announced the appointment of Wouter Latour, M.D., as its new Chief Executive Officer (CEO). In addition…
Forge Biologics Launches FUEL AAV Manufacturing Platform for Efficient Gene Therapy Production
Forge Biologics, a key player in Ajinomoto Bio-Pharma Services and a leading manufacturer of genetic medicines, has announced the launch of its FUEL™ manufacturing platform. This innovative platform aims to…
ImmunoPrecise Subsidiary Enters Material Transfer Agreement with Biotheus
ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA), an AI-driven biotherapeutics and technology company, and Biotheus Inc., a clinical-stage biotech specializing in biologics for oncology and inflammatory diseases, have announced the signing…
Arcus Biosciences to Trial Casdatifan and Volrustomig Combo in Renal Cancer
Arcus Biosciences, Inc. (NYSE: RCUS), a global biopharmaceutical company in the clinical stage, focused on developing innovative molecules and combination therapies for cancer patients, has announced a new collaboration with…